Approach to hemophagocytic syndromes

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome.
• It can be primary (genetic) due to gene mutations affecting immune cell function or secondary to other conditions.
• HLH represents the severe end of hyperinflammation, where the immune system causes self-damage.

Purpose of the Study:

• To discuss the genetic basis of HLH.
• To outline the clinical presentation and diagnostic challenges of HLH.
• To review management strategies and common complications of HLH.

Main Methods:

• Review of genetic factors contributing to primary HLH.
• Analysis of clinical manifestations across primary and secondary HLH.
• Discussion of diagnostic criteria and therapeutic approaches.

Main Results:

• Primary HLH involves genetic defects in immune cell cytotoxicity.
• Secondary HLH presents with similar clinical features but is triggered by external factors.
• No single sign is diagnostic; a comprehensive clinical evaluation is essential.

Conclusions:

• HLH requires prompt intervention to avoid irreversible organ damage.
• Understanding the genetic and clinical spectrum is key for accurate diagnosis.
• Effective management addresses the underlying cause and controls hyperinflammation.